Type
Business expansion
Country
Belgium
Region
Région Wallonne;
Location of affected unit(s)
Rixensart, Wavre, Gembloux, Genval
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

600 jobs
Number of planned job creations
Job creation
Announcement Date
19 September 2009
Employment effect (start)
1 September 2009
Foreseen end date
31 December 2009

Description

The pharmaceutical company Glaxo Smith Kline (GSK) is about to recruit 600 new workers on its Belgian sites. Because GSK has been chosen to manufacture the vaccine for the influenza virus A/H1NI, the company needs more graduates in chemistry and biology.


Sources

  • 19 September 2009: La Dernière Heure

Citation

Eurofound (2009), Glaxo Smith Kline, Business expansion in Belgium, factsheet number 69574, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/69574.